Buy the Book PDA Download

Update Me E-mail alerts The Merck Manual Minute

Print This Topic Email This Topic

Binge eating disorder is characterized by recurrent episodes of consuming large amounts of food with a feeling of loss of control. It is not followed by inappropriate compensatory behavior, such as self-induced vomiting or laxative abuse. Diagnosis is clinical.

Binge eating disorder affects about 3.5% of women and 2.0% of men in the general population. Unlike bulimia nervosa, binge eating disorder occurs most commonly in obese people and contributes to excessive caloric intake; it may be present in ≥ 30% of patients in some weight reduction programs. People with binge eating disorder are older, and a higher percentage are men than in anorexia nervosa or bulimia nervosa.

People with binge eating disorder are usually distressed by it, especially if they are trying to lose weight. Clinical depression and preoccupation with body shape, weight, or both are more common in obese people with binge eating disorder than in obese people who are not binge eaters.

Diagnosis

Diagnosis requires binge eating for 2 days/wk for at least 6 mo and a sense of lack of control over eating, according to research criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR). Other criteria include presence of ≥ 3 of the following:

• Eating much more rapidly than normal
• Eating until feeling uncomfortably full
• Eating large amounts of food when not feeling physically hungry
• Eating alone because of embarrassment
• Feeling disgusted, depressed, or guilty after overeating

Treatment

• Cognitive-behavioral therapy
• Sometimes interpersonal psychotherapy
• Consider drug therapy with SSRIs or sibutramine Some Trade Names
  MERIDIA
  Click for Drug Monograph
  

Cognitive-behavioral therapy (CBT) is the most researched and best supported treatment. Interpersonal psychotherapy (IPT) and dialectical behavior therapy also may be effective. Both CBT and IPT result in remission rates of ≥ 60%; improvement is usually well-maintained over the long-term. These treatments do not produce significant weight loss in obese patients.

Conventional behavioral weight loss treatment has short-term effectiveness in reducing binge eating but patients tend to relapse. Antidepressant drugs also have short-term effectiveness in eliminating binge eating, but long-term effectiveness is unknown. Initial results with the anti-appetite drug sibutramine Some Trade Names
MERIDIA
Click for Drug Monograph
are promising.

Last full review/revision July 2008 by Albert J. Stunkard, MD; G. Terence Wilson, PhD

Content last modified July 2008